Dietary quercetin intake and risk of gastric cancer: Results from a population-based study in Sweden

A. M. Ekström, M. Serafini, O. Nyrén, A. Wolk, C. Bosetti, R. Bellocco

Research output: Contribution to journalArticle


Background: To study the impact of the dietary antioxidant quercetin on risk of gastric adenocarcinoma. Patients and methods: Using data from a large Swedish population-based case-control study of gastric cancer (505 cases and 1116 controls), we studied the association between quercetin and risk of anatomic (cardia/noncardia) and histological (intestinal and diffuse) subtypes of gastric cancer. Results: We found strong inverse associations between quercetin and the risk of noncardia gastric adenocarcinoma, with an adjusted odds ratio (OR) of 0.57 (95% confidence interval 0.40-0.83) for the highest quintile (≥11.9 mg) of daily quercetin intake relative to the lowest quintile of intake (6 mg quercetin/day). Conclusions: High dietary quercetin intake is inversely related to the risk of noncardia gastric adenocarcinoma, and the protection appears to be particularly strong for women exposed to oxidative stress, such as tobacco smoking.

Original languageEnglish
Pages (from-to)438-443
Number of pages6
JournalAnnals of Oncology
Issue number2
Publication statusPublished - 2011



  • Antioxidants
  • Case-control study
  • Gastric cancer
  • Quercetin
  • Sweden

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this